These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35304797)

  • 1. Self-administration of gender-affirming hormones and supratherapeutic dosing are relatively common in Japanese transgender women.
    Baba T; Endo T; Ikeda U; Ikeda H; Ichihara K; Masumori N; Saito T
    J Obstet Gynaecol Res; 2022 Aug; 48(8):2208-2213. PubMed ID: 35304797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
    Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
    J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
    Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
    J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of testicular function and spermatogenesis in transgender women.
    Vereecke G; Defreyne J; Van Saen D; Collet S; Van Dorpe J; T'Sjoen G; Goossens E
    Hum Reprod; 2021 Jan; 36(1):5-15. PubMed ID: 33257947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Gender-Affirming Hormone Therapy Requirements.
    Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
    LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrinological and ovarian histological investigations in assigned female at birth transgender people undergoing testosterone therapy.
    Borrás A; Manau MD; Fabregues F; Casals G; Saco A; Halperin I; Mora M; Goday A; Barral Y; Carmona F
    Reprod Biomed Online; 2021 Aug; 43(2):289-297. PubMed ID: 34244072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
    van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
    J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the most anticipated change induced by treatment using gender-affirming hormones in individuals with gender incongruence?
    Masumori N; Baba T; Abe T; Niwa K
    Int J Urol; 2021 May; 28(5):526-529. PubMed ID: 33465834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Headache prevalence in transgender and gender diverse youth: A single-center case-control study.
    Hranilovich JA; Millington K
    Headache; 2023 Apr; 63(4):517-522. PubMed ID: 36988085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic effects of hormonal treatment in transgender males: Safety of the testosterone gender-affirming therapy.
    Milionis C; Ilias I; Venaki E; Koukkou E
    Int J Risk Saf Med; 2023; 34(1):21-28. PubMed ID: 35964205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
    van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
    J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol and Testosterone Concentrations Among Thai Transgender Women in a Transgender-Led, Integrated Gender-Affirming Care and Sexual Health Clinic: A Real-World Analysis.
    Hiransuthikul A; Janamnuaysook R; Getwongsa P; Peelay J; Samitpol K; Amatsombat T; Chumnanwet P; Chancham A; Kongkapan J; Rueannak J; Himma L; Srimanus P; Teeratakulpisarn N; Avery M; Wansom T; Mills S; Ramautarsing RA; Phanuphak N
    Transgend Health; 2022 Nov; 7(6):539-547. PubMed ID: 36514686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
    J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
    Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
    Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence.
    Defreyne J; Vantomme B; Van Caenegem E; Wierckx K; De Blok CJM; Klaver M; Nota NM; Van Dijk D; Wiepjes CM; Den Heijer M; T'Sjoen G
    Andrology; 2018 May; 6(3):446-454. PubMed ID: 29602229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-affirming hormone treatment causes changes in gender phenotype in a 12-lead electrocardiogram.
    Saito N; Nagahara D; Ichihara K; Masumori N; Miura T; Takahashi S
    Heart Rhythm; 2021 Jul; 18(7):1203-1209. PubMed ID: 33706005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does sex hormone treatment reverse the sex-dependent stress regulation? A longitudinal study on hypothalamus-pituitary-adrenal (HPA) axis activity in transgender individuals.
    Fuss J; Claro L; Ising M; Biedermann SV; Wiedemann K; Stalla GK; Briken P; Auer MK
    Psychoneuroendocrinology; 2019 Jun; 104():228-237. PubMed ID: 30897530
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.